UK Markets closed

Exicure, Inc. (XCUR)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
2.0400-0.1200 (-5.56%)
As of 11:35AM EDT. Market open.
Full screen
Trade prices are not sourced from all markets
Previous close2.1600
Open2.1000
Bid2.0400 x 900
Ask2.0700 x 800
Day's range2.0400 - 2.1500
52-week range2.0200 - 59.4000
Volume90,261
Avg. volume443,297
Market cap206.301M
Beta (5Y monthly)1.14
PE ratio (TTM)N/A
EPS (TTM)-0.7170
Earnings date09 Mar 2022 - 14 Mar 2022
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target est3.13
  • Business Wire

    Exicure, Inc. Announces Receipt of Nasdaq Notice of Non-compliance and Implementation of One-for-Thirty Reverse Stock Split

    CHICAGO, June 29, 2022--Exicure, Inc. (NASDAQ: XCUR), an early-stage biotechnology company focused on the development of next generation nucleic acid therapies targeting RNA to address both genetic and non-genetic neurological disorders and hair loss disorders, today announced that, following the implementation of a one-for-thirty reverse stock split at 5:00 p.m. EDT today, the Company’s common stock will begin trading on a split-adjusted basis on Nasdaq effective with the open of business tomor

  • Business Wire

    Exicure, Inc. Announces Adjournment of Annual Meeting of Stockholders

    CHICAGO, May 27, 2022--Exicure, Inc. (NASDAQ: XCUR), an early-stage biotechnology company focused on the development of next generation nucleic acid therapies targeting RNA to address both genetic and non-genetic neurological disorders and hair loss disorders, today announced that the Company’s Annual Meeting of Stockholders (the "Annual Meeting") held in virtual format on Friday, May 27, 2022 at 1:00 p.m. Central Time, was convened and adjourned until June 10, 2022 at 1:00 p.m. Central Time wit

  • Business Wire

    Exicure Announces Presentation at 2022 H.C. Wainwright Global Life Sciences Conference

    CHICAGO, May 17, 2022--Exicure today announced that CEO Matthias Schroff will provide a virtual presentation at the 2022 H.C. Wainwright Global Life Sciences Conference.